Dentsply Sirona

XRAY

Market cap $2.26B

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its patent cliff issue.

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Brickwood added 1,496,935 shares of XRAY, raising position value by $19.03 million. The transaction represented 15.2% of Brickwood's 13F reportable assets under management.

Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Dentsply Sirona Inc. (NASDAQ:XRAY) stock is trading lower on Thursday after weaker-than-expected third-quarter earnings and lowered guidance.

DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.

DENTSPLY SIRONA Inc. ( XRAY ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Wade Moody Daniel Scavilla - President, CEO & Director Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division David Saxon - Needham & Company, LLC, Research Division Jordan Bernstein - Stifel, Nicolaus & Company, Incorporated, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Ahmed Muhammad Rahat - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Allen Lutz - BofA Securities, Research Division Brandon Vazquez - William Blair & Company L.L.C.

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Dentsply International (XRAY) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.5 per share a year ago.